These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 5527165)

  • 1. The neuroleptics. 3. Pharmacology. Introduction.
    Van Rossum JM; Janssen PA; Boissier JR; Julou L; Loew DM; Moller Nielsen I; Munkvad I; Randrup A; Stille G; Tedeschi DH
    Mod Probl Pharmacopsychiatry; 1970; 5():23-32. PubMed ID: 5527165
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical and pharmacological classification of neuroleptics.
    Janssen PA
    Mod Probl Pharmacopsychiatry; 1970; 5():33-44. PubMed ID: 5535847
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction.
    Randrup A
    Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170
    [No Abstract]   [Full Text] [Related]  

  • 4. Definition and classification of neuroleptics.
    Arnold OH; Collard J; Deniker P; Ginestet D; Hippius H; Itil TM; Labhardt F; Leeds AA; Montanini R; Morozov G; Simon P; Villeneuve A
    Mod Probl Pharmacopsychiatry; 1970; 5():141-7. PubMed ID: 5527163
    [No Abstract]   [Full Text] [Related]  

  • 5. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
    Janssen PA; Niemegeers CJ; Schellekens KH; Dresse A; Lenaerts FM; Pinchard A; Schaper WK; van Nueten JM; Verbruggen FJ
    Arzneimittelforschung; 1968 Mar; 18(3):261-79. PubMed ID: 4386815
    [No Abstract]   [Full Text] [Related]  

  • 6. The neuroleptics. 5. Animal behavior.
    Buser P; Cook L; Giurgea C; Jacobsen E; Ray OS; Richelle M; Silverman AP; Stein L; Votava Z
    Mod Probl Pharmacopsychiatry; 1970; 5():85-108. PubMed ID: 5005610
    [No Abstract]   [Full Text] [Related]  

  • 7. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
    Khisti RT; Deshpande LS; Chopde CT
    Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurophysiological substrates of the pharmacological criteria for neuroleptics.
    Stille G
    Mod Probl Pharmacopsychiatry; 1970; 5():56-60. PubMed ID: 5527169
    [No Abstract]   [Full Text] [Related]  

  • 9. Methods for evaluation of long acting neuroleptic drugs in animals.
    Kazdová E; Dlabac A; Metysová J
    Act Nerv Super (Praha); 1972; 14(2):126-7. PubMed ID: 5064759
    [No Abstract]   [Full Text] [Related]  

  • 10. On the interaction between neuroleptics and antiparkinson drugs.
    Julou L
    Mod Probl Pharmacopsychiatry; 1970; 5():50-4. PubMed ID: 5527168
    [No Abstract]   [Full Text] [Related]  

  • 11. Is dopamine antagonism a requisite of neuroleptic activity?
    Greenblatt EN; Coupet J; Rauh E; Szucs-Myers VA
    Arch Int Pharmacodyn Ther; 1980 Nov; 248(1):105-19. PubMed ID: 6111298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromoperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidol.
    Niemegeers CJ; Janssen PA
    Arzneimittelforschung; 1974 Jan; 24(1):45-52. PubMed ID: 4406109
    [No Abstract]   [Full Text] [Related]  

  • 13. Antagonism by neuroleptics of abnormal behavior induced by activation of brain dopamine receptors.
    Van Rossum JM
    Mod Probl Pharmacopsychiatry; 1970; 5():65-7. PubMed ID: 5527171
    [No Abstract]   [Full Text] [Related]  

  • 14. Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Wauquier A
    Arzneimittelforschung; 1975 Aug; 25(8):1287-94. PubMed ID: 1242360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of neuroleptics upon repeated administration.
    Moller Nielsen I; Fjalland B; Pedersen V; Nymark M
    Psychopharmacologia; 1974 Jan; 34(2):95-104. PubMed ID: 4856370
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacology and physiology of stereotyped behavior.
    Randrup A; Munkvad I
    J Psychiatr Res; 1974; 11():1-10. PubMed ID: 4218871
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology and biochemistry of haloperidol.
    Niemegeers CJ; Laduron PM
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):3-8. PubMed ID: 14331
    [No Abstract]   [Full Text] [Related]  

  • 18. The prediction of sedative potency of neuroleptics.
    Loew DM
    Mod Probl Pharmacopsychiatry; 1970; 5():47-50. PubMed ID: 5527167
    [No Abstract]   [Full Text] [Related]  

  • 19. [Central effects of some adreno- and-or sympatholytic substances. 3. Ptosis, catalepsy, antagonism with respect to apomorphine and amphetamine].
    Boissier JR; Simon P; Giudicelli JF
    Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):68-80. PubMed ID: 5689547
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of hydroxyzine and oxylidine on the central nervous system].
    Novikova GV; Komendantova MV
    Farmakol Toksikol; 1971; 34(2):131-5. PubMed ID: 4397903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.